Sphingolipids in viral infection

Biological Chemistry

Volumn 396, Issue 6-7, 2015, Pages 585-595

  Schneider Schaulies, Jürgen ^a   Schneider Schaulies, Sibylle ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Ceramide; Sphingolipids; Sphingomyelinase; Sphingosine kinase; Viruses

Indexed keywords

GLUCOSYLCERAMIDE; SPHINGOLIPID; CERAMIDE; PHOSPHOTRANSFERASE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE KINASE;

EBOLAVIRUS; ENDOCYTOSIS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA A VIRUS; LIPID ANALYSIS; LIPID COMPOSITION; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; RHINOVIRUS; SIGNAL TRANSDUCTION; SINDBIS VIRUS; SPHINGOLIPID METABOLISM; VIROGENESIS; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS INFECTION; VIRUS RELEASE; VIRUS REPLICATION; CELL LINE; METABOLISM; VIRAL PHENOMENA AND FUNCTIONS;

CELL LINE; CERAMIDES; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE; VIRUS INTERNALIZATION; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 84957362388     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2014-0273     Document Type: Review

References (87)

1. Alfsen, A. and Bomsel, M. (2002). HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J. Biol. Chem. 277, 25649-25659.
2. Alvisi, G., Madan, V., and Bartenschlager, R. (2011). Hepatitis C virus and host cell lipids: an intimate connection. RNA Biol. 8, 258-269.
3. Amako, Y., Syed, G. H., and Siddiqui, A. (2011). Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein. J. Biol. Chem. 286, 11265-11274.
4. Avota, E., Gulbins, E., and Schneider-Schaulies, S. (2011). DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells. PLoS Pathog. 7, e1001290.
5. + T cells. Curr. Opin. HIV AIDS 6, 391-397.
6. Bollinger, C. R., Teichgraber, V., and Gulbins, E. (2005). Ceramideenriched membrane domains. Biochim. Biophys. Acta 1746, 284-294.
7. Bonsch, C., Zuercher, C., Lieby, P., Kempf, C., and Ros, C. (2010). The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization. J. Virol. 84, 11737-11746.
8. Brugger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F. T., and Krausslich, H. G. (2006). The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. USA 103, 2641-2646.
9. Burckhardt, C. J. and Greber, U. F. (2009). Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog. 5, e1000621.
10. Burckhardt, C. J., Suomalainen, M., Schoenenberger, P., Boucke, K., Hemmi, S., and Greber, U. F. (2011). Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host. Microb. 10, 105-117.
11. Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011). Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343.
12. Cook, D. G., Fantini, J., Spitalnik, S. L., and Gonzalez-Scarano, F. (1994). Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Virology 201, 206-214.
13. Cote, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., Chandran, K., et al. (2011). Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477, 344-348.
14. Dai, L., Plaisance-Bonstaff, K., Voelkel-Johnson, C., Smith, C. D., Ogretmen, B., Qin, Z., and Parsons, C. (2014). Sphingosine kinase-2 maintains viral latency and survival for KSHV-infected endothelial cells. PLoS One 9, e102314.
15. + T lymphocytes. J. Virol. 84, 10533-10542.
16. Dreschers, S., Franz, P., Dumitru, C., Wilker, B., Jahnke, K., and Gulbins, E. (2007). Infections with human rhinovirus induce the formation of distinct functional membrane domains. Cell Physiol. Biochem. 20, 241-254.
17. Dumitru, C. A., Dreschers, S., and Gulbins, E. (2006). Rhinoviral infections activate p38MAP-kinases via membrane rafts and RhoA. Cell Physiol. Biochem. 17, 159-166.
18. Ewers, H., Smith, A. E., Sbalzarini, I. F., Lilie, H., Koumoutsakos, P., and Helenius, A. (2005). Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc. Natl. Acad. Sci. USA 102, 15110-15115.
19. Finnegan, C. M. and Blumenthal, R. (2006). Fenretinide inhibits HIV infection by promoting viral endocytosis. Antiviral Res. 69, 116-123.
20. Finnegan, C. M., Rawat, S. S., Puri, A., Wang, J. M., Ruscetti, F. W., and Blumenthal, R. (2004). Ceramide, a target for antiretroviral therapy. Proc. Natl. Acad. Sci. USA 101, 15452-15457.
21. Finnegan, C. M., Rawat, S. S., Cho, E. H., Guiffre, D. L., Lockett, S., Merrill, A. H., Jr., and Blumenthal, R. (2007). Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J. Virol. 81, 5294-5304.
22. Fischl, W. and Bartenschlager, R. (2011). Exploitation of cellular pathways by Dengue virus. Curr Opin Microbiol. 14, 470-475.
23. Gassert, E., Avota, E., Harms, H., Krohne, G., Gulbins, E., and Schneider-Schaulies, S. (2009). Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression. PLoS Pathog 5, e1000623.
24. Geijtenbeek, T. B. and Gringhuis, S. I. (2009). Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465-479.
25. Gerl, M. J., Sampaio, J. L., Urban, S., Kalvodova, L., Verbavatz, J. M., Binnington, B., Lindemann, D., Lingwood, C. A., Shevchenko, A., Schroeder, C., et al. (2012). Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. J. Cell. Biol. 196, 213-221.
26. Grassme, H., Riehle, A., Wilker, B., and Gulbins, E. (2005). Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J. Biol. Chem. 280, 26256-26262.
27. Grassme, H., Riethmuller, J., and Gulbins, E. (2007). Biological aspects of ceramide-enriched membrane domains. Prog. Lipid Res. 46, 161-170.
28. Gringhuis, S. I., den Dunnen, J., Litjens, M., van der Vlist, M., and Geijtenbeek, T. B. (2009). Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10, 1081-1088.
29. Gulbins, E. and Grassme, H. (2002). Ceramide and cell death receptor clustering. Biochim. Biophys. Acta 1585, 139-145.
30. Gulbins, E., Dreschers, S., Wilker, B., and Grassme, H. (2004). Ceramide, membrane rafts and infections. J. Mol. Med. 82, 357-363.
31. Hammache, D., Pieroni, G., Yahi, N., Delezay, O., Koch, N., Lafont, H., Tamalet, C., and Fantini, J. (1998a). Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J. Biol. Chem. 273, 7967-7971.
32. Hammache, D., Yahi, N., Pieroni, G., Ariasi, F., Tamalet, C., and Fantini, J. (1998b). Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. Biochem. Biophys. Res. Commun. 246, 117-122.
33. Harrison, A. L., Olsson, M. L., Jones, R. B., Ramkumar, S., Sakac, D., Binnington, B., Henry, S., Lingwood, C. A., and Branch, D. R. (2010). A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconj. J. 27, 515-524.
34. Hatch, S. C., Archer, J., and Gummuluru, S. (2009). Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cellmediated HIV-1 trans-infection. J. Virol. 83, 3496-3506.
35. Hayashi, Y., Nemoto-Sasaki, Y., Tanikawa, T., Oka, S., Tsuchiya, K., Zama, K., Mitsutake, S., Sugiura, T., and Yamashita, A. (2014). Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion. J. Biol. Chem. 289, 30842-30856.
36. Holopainen, J. M., Angelova, M. I., and Kinnunen, P. K. (2000). Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys J. 78, 830-838.
37. Izquierdo-Useros, N., Naranjo-Gomez, M., Archer, J., Hatch, S. C., Erkizia, I., Blanco, J., Borras, F. E., Puertas, M. C., Connor, J. H., Fernandez-Figueras, M. T., et al. (2009). Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113, 2732-2741.
38. Izquierdo-Useros, N., Naranjo-Gomez, M., Erkizia, I., Puertas, M. C., Borras, F. E., Blanco, J., and Martinez-Picado, J. (2010). HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog. 6, e1000740.
39. Izquierdo-Useros, N., Lorizate, M., Puertas, M. C., Rodriguez-Plata, M. T., Zangger, N., Erikson, E., Pino, M., Erkizia, I., Glass, B., Clotet, B., et al. (2012). Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol. 10, e1001448.
40. Jan, J. T., Chatterjee, S., and Griffin, D. E. (2000). Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 74, 6425-6432.
41. Khan, F., Proulx, F., and Lingwood, C. A. (2009). Detergent-resistant globotriaosyl ceramide may define verotoxin/glomerulirestricted hemolytic uremic syndrome pathology. Kidney Int. 75, 1209-1216.
42. Kumar, N., Xin, Z. T., Liang, Y., and Ly, H. (2008). NF-κB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82, 9880-9889.
43. Lehmann, M. J., Sherer, N. M., Marks, C. B., Pypaert, M., and Mothes, W. (2005). Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J. Cell. Biol. 170, 317-325.
44. Lingwood, C. A., Binnington, B., Manis, A., and Branch, D. R. (2010a). Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect. FEBS Lett. 584, 1879-1886.
45. Lingwood, C. A., Manis, A., Mahfoud, R., Khan, F., Binnington, B., and Mylvaganam, M. (2010b). New aspects of the regulation of glycosphingolipid receptor function. Chem. Phys. Lipids 163, 27-35.
46. Lingwood, D. and Simons, K. (2010). Lipid rafts as a membraneorganizing principle. Science 327, 46-50.
47. Lingwood, D., Binnington, B., Rog, T., Vattulainen, I., Grzybek, M., Coskun, U., Lingwood, C. A., and Simons, K. (2011). Cholesterol modulates glycolipid conformation and receptor activity. Nat. Chem. Biol. 7, 260-262.
48. Liu, S. T., Sharon-Friling, R., Ivanova, P., Milne, S. B., Myers, D. S., Rabinowitz, J. D., Brown, H. A., and Shenk, T. (2011). Synaptic vesicle-like lipidome of human cytomegalovirus virions reveals a role for SNARE machinery in virion egress. Proc. Natl. Acad. Sci. USA 108, 12869-12874.
49. Lund, N., Branch, D. R., Sakac, D., Lingwood, C. A., Siatskas, C., Robinson, C. J., Brady, R. O., and Medin, J. A. (2005). Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus. AIDS 19, 1543-1546.
50. Lund, N., Branch, D. R., Mylvaganam, M., Chark, D., Ma, X. Z., Sakac, D., Binnington, B., Fantini, J., Puri, A., Blumenthal, R., et al. (2006). A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection. AIDS 20, 333-343.
51. Lund, N., Olsson, M. L., Ramkumar, S., Sakac, D., Yahalom, V., Levene, C., Hellberg, A., Ma, X. Z., Binnington, B., Jung, D., et al. (2009). The human P (k) histo-blood group antigen provides protection against HIV-1 infection. Blood 113, 4980-4991.
52. Machesky, N. J., Zhang, G., Raghavan, B., Zimmerman, P., Kelly, S. L., Merrill, A. H., Jr., Waldman, W. J., Van Brocklyn, J. R., and Trgovcich, J. (2008). Human cytomegalovirus regulates bioactive sphingolipids. J. Biol. Chem. 283, 26148-26160.
53. Magerus-Chatinet, A., Yu, H., Garcia, S., Ducloux, E., Terris, B., and Bomsel, M. (2007). Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells. Virology 362, 67-74.
54. Mercer, J. and Helenius, A. (2008). Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320, 531-535.
55. Mercer, J. and Helenius, A. (2009). Virus entry by macropinocytosis. Nat. Cell. Biol. 11, 510-520.
56. Merz, A., Long, G., Hiet, M. S., Brugger, B., Chlanda, P., Andre, P., Wieland, F., Krijnse-Locker, J., and Bartenschlager, R. (2011). Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J. Biol. Chem. 286, 3018-3032.
57. Miller, E. H., Obernosterer, G., Raaben, M., Herbert, A. S., Deffieu, M. S., Krishnan, A., Ndungo, E., Sandesara, R. G., Carette, J. E., Kuehne, A. I., et al. (2012a). Ebola virus entry requires the host-programmed recognition of an intracellular receptor. Embo J. 31, 1947-1960.
58. Miller, M. E., Adhikary, S., Kolokoltsov, A. A., and Davey, R. A. (2012b). Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection. J. Virol. 86, 7473-7483.
59. Monick, M. M., Cameron, K., Powers, L. S., Butler, N. S., McCoy, D., Mallampalli, R. K., and Hunninghake, G. W. (2004). Sphingosine kinase mediates activation of extracellular signal-related kinase and Akt by respiratory syncytial virus. Am. J. Respir. Cell. Mol. Biol. 30, 844-852.
60. Mothes, W., Sherer, N. M., Jin, J., and Zhong, P. (2010). Virus cell-tocell transmission. J. Virol. 84, 8360-8368.
61. Müller, N., Collenburg, L., Grssmé, H., and Schneider-Schaulies, S. (2014). Neutral sphingomyelinase in physiological and measles virus induced T cell suppression. PLoS Pathog. 10, e1004574.
62. Ng, C. G. and Griffin, D. E. (2006). Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis. J. Virol. 80, 10989-10999.
63. Ng, C. G., Coppens, I., Govindarajan, D., Pisciotta, J., Shulaev, V., and Griffin, D. E. (2008). Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivity. Proc. Natl. Acad. Sci. USA 105, 16326-16331.
64. Perera, M. N., Ganesan, V., Siskind, L. J., Szulc, Z. M., Bielawski, J., Bielawska, A., Bittman, R., and Colombini, M. (2012). Ceramide channels: influence of molecular structure on channel formation in membranes. Biochim. Biophys. Acta 1818, 1291-1301.
65. Puri, A., Rawat, S. S., Lin, H. M., Finnegan, C. M., Mikovits, J., Ruscetti, F. W., and Blumenthal, R. (2004). An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells. AIDS 18, 849-858.
66. Rahmaniyan, M., Curley, R. W., Jr., Obeid, L. M., Hannun, Y. A., and Kraveka, J. M. (2011). Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. J. Biol. Chem. 286, 24754-24764.
67. Ramkumar, S., Sakac, D., Binnington, B., Branch, D. R., and Lingwood, C. A. (2009). Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. Glycobiology 19, 76-82.
68. Rawat, S. S., Gallo, S. A., Eaton, J., Martin, T. D., Ablan, S., Kewal Ramani, V. N., Wang, J. M., Blumenthal, R., and Puri, A. (2004). Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. J. Virol. 78, 7360-7368.
69. Rawat, S. S., Zimmerman, C., Johnson, B. T., Cho, E., Lockett, S. J., Blumenthal, R., and Puri, A. (2008). Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion. Mol. Membr. Biol. 25, 830000-94.
70. Sainz, B., Jr., Barretto, N., Martin, D. N., Hiraga, N., Imamura, M., Hussain, S., Marsh, K. A., Yu, X., Chayama, K., Alrefai, W. A., et al. (2012). Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 18, 281-285.
71. Schelhaas, M., Ewers, H., Rajamaki, M. L., Day, P. M., Schiller, J. T., and Helenius, A. (2008). Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog. 4, e1000148.
72. Seo, Y. J., Blake, C., Alexander, S., and Hahm, B. (2010). Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. J. Virol. 84, 8124-8131.
73. Seo, Y. J., Pritzl, C. J., Vijayan, M., Bomb, K., McClain, M. E., Alexander, S., and Hahm, B. (2013). Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection. PLoS One 8, e75005.
74. Sherer, N. M., Lehmann, M. J., Jimenez-Soto, L. F., Horensavitz, C., Pypaert, M., and Mothes, W. (2007). Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell. Biol. 9, 310-315.
75. Tani, H., Shiokawa, M., Kaname, Y., Kambara, H., Mori, Y., Abe, T., Moriishi, K., and Matsuura, Y. (2010). Involvement of ceramide in the propagation of Japanese encephalitis virus. J. Virol. 84, 2798-2807.
76. Tanner, L. B., Chng, C., Guan, X. L., Lei, Z., Rozen, S. G., and Wenk, M. R. (2014). Lipidomics identifies a requirement for peroxisomal function during influenza virus replication. J. Lipid Res. 55, 1357-1365.
77. Utermohlen, O., Herz, J., Schramm, M., and Kronke, M. (2008). Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology 213, 307-314.
78. Vieira, C. R., Munoz-Olaya, J. M., Sot, J., Jimenez-Baranda, S., Izquierdo-Useros, N., Abad, J. L., Apellaniz, B., Delgado, R., Martinez-Picado, J., Alonso, A., et al. (2010). Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains. Chem Biol 17, 766-775.
79. Vijayan, M. and Hahm, B. (2014). Influenza viral manipulation of sphingolipid metabolism and signaling to modulate host defense system. Scientifica (Cairo) 2014, 793815.
80. Vijayan, M., Seo, Y. J., Pritzl, C. J., Squires, S. A., Alexander, S., and Hahm, B. (2014). Sphingosine kinase 1 regulates measles virus replication. Virology 450-451, 55-63.
81. Voisset, C., Lavie, M., Helle, F., Op De Beeck, A., Bilheu, A., Bertrand-Michel, J., Terce, F., Cocquerel, L., Wychowski, C., Vu-Dac, N., et al. (2008). Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell Microbiol. 10, 606-617.
82. Walsh, K. B., Marsolais, D., Welch, M. J., Rosen, H., and Oldstone, M. B. (2010). Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection. Virology 397, 260-269.
83. Walsh, K. B., Teijaro, J. R., Wilker, P. R., Jatzek, A., Fremgen, D. M., Das, S. C., Watanabe, T., Hatta, M., Shinya, K., Suresh, M., et al. (2011). Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 108, 12018-12023.
84. Yamane, D., Zahoor, M. A., Mohamed, Y. M., Azab, W., Kato, K., Tohya, Y., and Akashi, H. (2009). Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis. J. Biol. Chem. 284, 13648-13659.
85. Yu, H., Alfsen, A., Tudor, D., and Bomsel, M. (2008). The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl ceramide, is structure-dependent. Cell Calcium 43, 73-82.
86. Zeidan, Y. H., Jenkins, R. W., and Hannun, Y. A. (2008). Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway. J. Cell. Biol. 181, 335-350.
87. Zha, X., Pierini, L. M., Leopold, P. L., Skiba, P. J., Tabas, I., and Maxfield, F. R. (1998). Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell. Biol. 140, 39-47.